Dr. Jill M. Moore, MD

Dr. Moore practices at Market Street Dermatology in Minneapolis, Minnesota.

Dr. Moore's NPI, 1922260413, was assigned on June 26, 2008. Dr. Moore holds Minnesota license 75778.

Dr. Moore's primary practice is Market Street Dermatology, at 275 Market St, Minneapolis, MN 55405 in Hennepin County. The practice phone is (612) 746-4144.

Dr. Moore's primary practice is Market Street Dermatology in Minneapolis, Minnesota. Dr. Moore is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is Market Street Dermatology. Dmand AI also links Dr. Moore to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Moore's licenses on file in 2 states: Minnesota and Oregon.

CMS data shows 958 Medicare services from Dr. Moore across 9 procedure codes in 2024, for 356 Medicare patients. Medicare paid $37,116 for them. Every service was in an office.

CMS counts 356 Medicare patients who saw Dr. Moore in 2024. The largest group is 65 to 74, with 172 patients. 67% of them have high cholesterol, and 53% have high blood pressure. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 42, with 67% women.

In 2024, Dr. Moore wrote 517 Medicare Part D claims for 256 patients. 91% of them were for generic drugs. CMS names the drug for 365 of them, across 13 drugs with 11 or more claims each, at $94,154 in total drug cost. In 2023, CMS named 594 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Moore for performance year 2024, reported as part of a group. CMS counts 103 procedures of removal of skin lesions by Dr. Moore, more than 75% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 91 general payments to Dr. Moore from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Janssen Pharmaceuticals, Inc paid the most, $562.